Nevertheless, the company persists in reporting robust figures for both revenue and profit. In FY25, its net profit skyrocketed by 448% to INR 353.2 Cr, up from INR 64 Cr in the previous fiscal year. Operating revenue also surged by 45% during the fiscal year in question, increasing to INR 4,977.2 Cr from INR 3,437.7 Cr in FY24.
It recently obtained the Reserve Bank of India’s (RBI) in-principle approval for its subsidiary PB Pay to function as a payment aggregator. Additionally, its healthcare division, PB Healthcare, secured $218 million in seed funding in May of this year.
On the BSE, shares of PB Fintech ended the trading session yesterday with a decrease of 0.